Trial Profile
Effectiveness of PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae in 2 to 5 Years Old Healthy Chinese Children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Hib vaccine
- Indications Pneumococcal infections; Pneumonia
- Focus Therapeutic Use
- 05 May 2021 Results (n=412) published in the Vaccine.
- 10 Jul 2014 New trial record